Complicaciones y manejo del síndrome antifosfolipídico en el embrazo

Abstract

Currently the antiphospholipid syndrome has had an increase in the population, it is more prevalent in women who are in a gestational process, complications can occur in mothers and in the fetus, an investigation of the complications should be performed, since this pathology can trigger what would be; thrombophilia, intrauterine growth restriction, preeclampsia, abortions, fetal death, the management of this pathology is paramount to avoid complications of the pathology. With all the knowledge about this autoimmune syndrome and the prevalence of this disease, an early diagnosis should be taken into account, as well as a better management of this pathology with respect to complications and their adequate management. This review aims to determine the complications of antiphospholipid syndrome in pregnancy and its management. The main observations were the presence of antiphospholipid antibodies (AAF), lupus antibodies (LA), anticardiolipin antibodies (ACL), which cause maternal-fetal complications. It can be concluded that the antiphospholipid syndrome is an autoimmune disease, which is characterized by being prothrombotic in addition to a high percentage of maternal-fetal morbidity and irreversible complications. This topic is relevant because it allows us to recognize the complications caused by the antibodies present in this pathology and to know the optimal management in the presence of complications. Results The results obtained were that the presence of antiphospholipid antibodies, lupus antibodies, anticardiolipin antibodies, these cause a prolongation of the activated partial thromboplastin time and produce a prothrombotic state, in this literature review is expected to determine all possible complications that can occur in pregnancy, This disease when it occurs in a gestation process can present complications in the mother and the fetus, it will be possible to determine an optimal management of the antiphospholipid syndrome in patients who are in a gestation period and thus be able to better help the mother and the fetus, since with an excellent management we can avoid the possible complications that this syndrome can present in pregnant patients